LC Research – Lymphoma Coalition

Home / News / LC Research

Patient-reported experiences with cancer-related...

Incidence and Impact of...

Accepted for publication at the European Hematology Association (EHA) 2026 Congress, taking place from 11–14 June 2026 in Stockholm, Sweden. Diffuse large B-cell lymphoma (DLBCL) is an aggressive form of...

Patient-reported experiences with cancer-related...

Variances In Patient Experiences...

Presented during the 52nd Annual Meeting of the EBMT, March 22–25, 2026 in Madrid, Spain. Large B-cell lymphoma (LBCL) is an aggressive form of lymphoma where timely, effective treatment decisions...

Variances In Patient-Reported Experiences...

Presented during the ASH Annual Meeting on December 6 in Orlando, Florida. Shared decision-making (SDM) is essential to patient-centred care, yet experiences vary significantly among people with diffuse large B-cell...

Evolving Patient-Reported Value of...

Presented during the ASH Annual Meeting on December 6 in Orlando, Florida. Follicular lymphoma (FL) is a chronic, incurable lymphoma marked by repeated cycles of treatment and remission. As individuals...

Recent Research Publication: Bridging...

Published article: “Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe,” in HemaSphere. This publication examines the unmet need in large B-cell lymphoma (LBCL)...

Recent Research Publication: Addressing...

This study explores the unmet needs of people living with graft-versus-host disease (GVHD) across Europe, focusing on improving patient care, support, and research. The research is based on insights gathered...

Unaddressed Side-Effects and Confidence...

Presented during the EHA Congress on June 12-15 in Milan, Italy. Patients with lymphoma or CLL frequently experience side effects that affect their wellbeing. Managing these side effects is a...

Patient Perspective Psychosocial Impact...

Presented during the 2025 AACR Annual Meeting on April 25-30 in Chicago, Illinois. Patients who have received treatment for lymphoma or chronic lymphocytic leukemia (CLL) experience numerous side effects which...